These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Lewis K; Saubolle MA; Tenover FC; Rudinsky MF; Barbour SD; Cherry JD Pediatr Infect Dis J; 1995 May; 14(5):388-91. PubMed ID: 7638015 [No Abstract] [Full Text] [Related]
8. From the Centers for Disease Control and Prevention. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994. JAMA; 1995 Jan; 273(1):13-4. PubMed ID: 7996637 [No Abstract] [Full Text] [Related]
9. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996 [TBL] [Abstract][Full Text] [Related]
10. [Bordetella pertussis: a case of whooping cough in a newborn]. Ben Hassine A; Bejaoui M; Lakhoua M; Ben Redjeb S Tunis Med; 1994 Dec; 72(12):719-22. PubMed ID: 7624981 [No Abstract] [Full Text] [Related]
11. Erythromycin for pertussis: probable reasons for past failures. Bass JW Lancet; 1985 Jul; 2(8447):147. PubMed ID: 2862331 [No Abstract] [Full Text] [Related]
12. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)]. Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173 [No Abstract] [Full Text] [Related]
13. [Fundamental and clinical studies of T-1982 (cefbuperazone) in the pediatric field]. Motohiro T; Koga T; Tomita N; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Koga Y; Takajo N; Araki H; Tanaka K; Imai S; Yuasa T; Nagayama K; Tsugawa S; Tanaka Y; Shimada Y; Aramaki S; Iriki T; Cho H; Yamamoto M; Komatsu Y; Tanaka C; Yuge K; Toyoda A; Matsunaga S; Yukizane S; Takechi T; Matsuo H; Eto Y; Matsuyuki M Jpn J Antibiot; 1983 Apr; 36(4):888-909. PubMed ID: 6348343 [No Abstract] [Full Text] [Related]
15. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada. Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412 [No Abstract] [Full Text] [Related]
16. Where macrolide resistance is prevalent. Li Y; Liu X; Zhang B; He Q; Wang Z APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275 [No Abstract] [Full Text] [Related]
17. [Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion]. Fosse T; Raoult D; David MF; Garnier JM; Arnolds M; Gallais H; Giraud F Pathol Biol (Paris); 1983 Jun; 31(6):477-9. PubMed ID: 6224124 [TBL] [Abstract][Full Text] [Related]
18. Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis. Maesen FP; Davies BI; Brouwers J; Salemans T; Nelissen-Wamper M; Debruyne H J Antimicrob Chemother; 1983 Feb; 11(2):115-23. PubMed ID: 6219980 [TBL] [Abstract][Full Text] [Related]
19. [Fundamental and clinical studies of CS-1170 in children (author's transl)]. Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T; Yamamoto I; Nanba I; Okuhara K; Kanaoka T; Yamagami M; Mochizuki Y; Ono Y; Teramura F; Shinomiya K Jpn J Antibiot; 1979 Jan; 32(1):41-59. PubMed ID: 423366 [No Abstract] [Full Text] [Related]